Page 3 - Vector Center News Today

The slower people get vaccinated the quicker the virus adapts, Anna Popova stressed

"I think it is an element of competition. Until Pfizer covers a certain part of the market, it is pure economics," Denis Manturov said when asked about the problem of mutual recognition of coronavirus vaccines

Nessun caso del ceppo Iota del Covid-19 identificato negli Stati Uniti è stato rilevato in Russia. Lo dice il centro di ricerca Vector dell'autorità russa per la salute dei consumatori Rospotrebnadzor. (ANSA)

Дэлхий дахин хязгаарлалт, дархлаажуулалтын тусламжтайгаар цар тахалтай тэмцсээр байна. Зургадугаар сарын 17-ны байдлаар дэлхий даяар 178 сая гаруй хүн халдвар авсанаас 3.8 сая гаруй хүн нас барж, 162 

Denis Manturov noted that the serial production of Sputnik V, as well as substances for the subsequent increase in the production of this vaccine, has been established on a massive scale

The Russian president pointed out that all four vaccines registered in Russia had proved effective

MOSCOW, May 7. /TASS/. Around 500,000 doses of the EpiVacCorona Covid-19 vaccine have been dispatched to Russian regions, Tatiana Nepomnyashchikh, deputy head of the Vector Center, the vaccine developer, said on Friday. "Slightly less than half a million doses have been sent to regions," she said in an interview with the Vesti evening news roundup on the Rossiya-1 television channel. EpiVacCorona was the second coronavirus vaccine to be registered in Russia, on October 14, 2020. Mass production...

Russia rolls out over 31 mln sets of coronavirus vaccine doses, says deputy PM The Sputnik V jab developed by the Russian Health Ministry’s Gamaleya Center is the leader among domestic vaccines, according to the high-ranking official Read also MOSCOW, May 6. /TASS/. Russian producers have rolled out over 31.9 million sets of coronavirus vaccine doses, Deputy Prime Minister Tatyana Golikova said during a video conference with President Vladimir Putin of Russia on Thursday. "As of today, all...

Vector holding clinical trials to boost immunity with 3 shots of EpiVacCorona vaccine - developer MOSCOW. May 5 (Interfax) - The Vector Center of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing (Rospotrebnadzor) is testing the possibility of administering three shots of the EpiVacCorona coronavirus vaccine as a way to enhance the effect of antibodies, head of the Vector department for zoonotic infections Alexander Ryzhikov said. "We have tested this, the t...

© Sputnik / Timur Batyrshin Russian vaccine Sputnik V for the prevention of coronavirus infection covid-19. In August last year, Russia became the first country in the world to register a vaccine against Covid-19. But eight months later, despite Sputnik Vs International success, theres been a slow uptake domestically for inoculation. Thats according to Kremlin spokesman Dmitry Peskov, who revealed that the current logistics are coping well, but too few people want to receive the jab. This is ...